S&P 500
$5,802.82
-0.7%
-$39.19
DJI
$41,603.07
-0.6%
-$256.02
NASDAQ
$18,737.21
-1.0%
-$188.53
Bitcoin
108,080.00
-0.2%
-232.06
AAPL
$195.55
-2.9%
-$5.81
AMZN
$201.33
-0.9%
-$1.77
GOOG
$169.68
-1.3%
-$2.30
META
$627.70
-1.4%
-$8.87
MSFT
$451.11
-0.8%
-$3.75
NVDA
$131.48
-1.0%
-$1.36
TSLA
$339.93
-0.3%
-$1.11
Evoke Pharma (NASDAQ: EVOK)
$3.67
(-0.8%)
-$0.03
Price as of May 23, 2025, 2:43 p.m. ET
Evoke Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Evoke Pharma Company Info
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.